SDC1 and Miyoshi myopathy: However, the results in patient-derived CD138+ cells underscore our findings in cell lines and warrant further research with a larger, controlled patient cohort to validate the use of PHGDH as a diagnostic tool to determine BTZ sensitivity in MM and other hematologic diseases.